American Law Uber Alles?

How far can American hegemony extend when it comes to laying down the law of international transactions?

Buried in Section B of yesterday’s Wall Street Journal are two articles which suggest that the United States, the world’s most robust economy, is attempting to not only establish a capitalist world, but also to bring along American legal structures that will regulate it.

A Federal Court of Appeals is now determining whether Motorola can bring a treble damages anti-trust case for price fixing against a group of Asian companies which fixed the price on liquid crystal display panels. Motorola purchased about $5,000,000,000 worth of LCD panels for its Razr phones and other uses, but purchased them (fully manufactured) through foreign based affiliates, without United States contact, in 99% of the cases. Do our anti-trust laws reach sales by foreign companies, to foreign purchasers which may be owned ultimately by United States companies, and which occur offshore?

The SEC and the DOJ long have been vigorous in enforcing the United States’ Foreign Corrupt Practices Act, which prohibits bribery of government agencies and government owned companies around the world. The WSJ reports a reduced fine to Avon, an American company, for bribes paid through subsidiaries in Africa and Australia, and the SEC suggests that the fines were greatly reduced by Avon self-reporting its violations to the SEC. DOJ Criminal Fraud Section noted that voluntary disclosure is “a huge factor” in fixing sanctions. The article contrasts Avon ($5,000,000 fine) to Marubeni, a Japanese trading company which did not report and this year agreed to pay $88,000,000 in fines. A commentator, cited in this article, noted that foreign companies are particularly insensitive to the subtle DOJ message that self-reporting is the path to a better economic result.

The international nature of all business raises the need for an international matrix of appropriate, non-obtrusive regulation. Will the relatively strict American legal system end up as the international standard?

And, if you want to truly understand the international nature of things, note that Motorola, claiming anti-trust violations by its Asian vendors, recently was purchased by China’s Lenovo. We have a Chinese parent claiming violation of United States anti-trust laws by Asian vendors supplying LCD screens to non-US subsidiaries outside the United States.

Trends in board’s role in strategy

 The just-released Blue Ribbon Report of the National Association of Corporate Directors on the board’s role in corporate strategy identifies the growing complexity of the marketplace, and the accelerating pace of change, requiring a “new level of board engagement.” Since directors long have considered strategic development as their core obligation, what more is being suggested?

Although the Report is full of specifics and flow charts which are useful, the bottom-line distillate is to move strategic discussion from an annual or quarterly basis to a continual process, identifying strategy as a year round central focus. This new focus is driven by marketplace realities, not by any change in the underlying law.

Not to be critical of the specific recommendations of the Report, which are both informative and cautionary, but one can read the report as primarily suggesting “do more of the same but do it better.” There are no startling “how to do it” revelations, which when you think about it is not surprising.

One interesting suggested innovation did catch my attention: executive sessions at the start and finish of every board meeting to permit independent directors to discuss strategy. The trend towards greater use of executive sessions, rubbing up against the practicalities of timing for board meetings, continues onward.

To the extent these NACD recommendations find their way into the directorship community, we might anticipate: it will take more time to be a director; there will be greater pressure in off-loading the other demands of directorship in favor of greater focus on strategy, which may create time tensions relative to committee service; there may be a subtle rethinking of the definition of a “good director” and an attempt to define the specific slot(s) as a “strategic director;” a change, through decided case law, in the standard of diligence required from directors under the so-called Caremark standard of duty to monitor (that whole area already is fuzzy in terms of its actual scope); and, a necessarily closer correlation between strategic consideration and enterprise risk management in a fluid environment.

Finally, it is good for directors to remember the following working definition of strategy: “the means to create economic value by gaining competitive advantage through unique value proposition.”

Director liability in insolvent companies

Much has been written, but few useful cases decided, defining the role of corporate directors of a company which is insolvent or within the “zone of insolvency.” A deep dive into that debate is beyond the scope of this post, but counselors to corporations under financial stress might want to take a look at the October 1st decision in Quadrant Structured Products decided by Delaware Chancery Court.

You don’t have to be a lawyer to understand the broad teaching here: directors do not owe any direct duty at any time to creditors; creditors can only make a claim against directors on a derivative basis which is to say, where they hold the position of the stakeholders in the corporation and the directors have breached their obligation to the corporation.

What is the standard for determining if a director is liable to a creditor for having managed an insolvent company in a manner which ultimately reduces the enterprise value to the creditors?

Directors should be comforted to know that, generally speaking, the “business judgment rule” applies. Even if a company is insolvent, if directors in good faith believe that by taking risk, spending money, etc. they can increase the value of the enterprise as a whole, then they are entitled to try and they are protected from liability if they have taken reasonable (and not self-interested) steps in that effort. (I do not here deal with issues created by director self-dealing, but there is even good news in the decision on that front.)

Globally, there is much discussion as to the duty of directors to creditors, but in the long run seldom resulting in any strategic adjustment. Typically: directors and management at all times want to build value, not waste it; strategic decisions in that context involve risk; many decisions will prove to have negative impact on value; good faith rational judgment by boards, even when a company is underwater, will be protected (at least in Delaware) from derivative claims asserted by creditors who have ended up short. Insolvency “does not mean that the directors cannot choose to continue the firm’s operations in the hope they can expand the inadequate pie such that the firm’s creditors get a greater recovery.”

Anatomy of a Pharma Exit

How does a bio pharma company with no sales, an FDA order to cease trials on its principal drug candidate, and a burn rate that has absorbed nine figures manage to nonetheless exit with a $3.85 billion dollar enterprise value?

The “how to” was explained at the ACG-Boston breakfast meeting, October 23rd, by Ron Renaud, former President and CEO of Idenix Pharmaceutical.

Idenix was doing research in the hot but highly competitive area of infectious diseases, including hepatitis and HIV, relying on small molecule research in an area described by Renaud as “nucleoside chemistry.” Notwithstanding initial backing from MPM Capital, Nomura and corporate partner Novartis (which also purchased 54% of the company in 2003, from then-shareholders, for $255,000,000), and with subsequent raises of an additional $200,000,000, by mid-2013 Idenix nonetheless found itself behind its competition (particularly Gilead, Vertex and Bristol Meyers). The company adopted a strategic plan to build a single pharmaceutical, administered by pill, which would address most forms of type C hepatitis without reliance on Interferon. In late 2013, the company began clinical trials in the face of a patent law suit by Gilead, with first results available about April, 2014.

Suddenly, without final data available but in the light of acquisitions by larger pharmaceutical companies at substantial multiples, in June, 2014 Merck offered a buyout of $24.50 per share in cash, a 239% premium above market; the deal closed on August 6, 2014, with Merck proudly announcing that it had purchased a company which had a portfolio of promising drugs including some major hepatitis C “candidates.”

Certainly timing had a lot to do with the enterprise value received from Merck, coupled with the worldwide incidence of hepatitis C (indicating a significant and continuing global market).

Renaud also particularly credited several specifics for his ability to guide his company to such a robust exit:

Continuous transparent communication with major shareholders, who were thus not spooked by day-to-day developments in the marketplace.

The raising of an additional $100,000,000 in capital from one of its existing major investors at the start of 2014, which allowed the company credibly to state that it intended to develop and market its own pharmaceuticals, and was not available at distress sale prices.

Renaud’s cynical take: nothing drives up the desire to do a deal, or the valuation of that deal, like telling a major pharma company that you are just not for sale.

Voter Access under Attack

As the elections approach, news reports have been full of legal battles surrounding efforts in various states to restrict access to the voting booth. These efforts may be traced back to the results of the 2008 election, which might otherwise be interpreted as reflecting an inter-racial detente in American society; however, it may not be working out that way.

Attorney Dale Ho, Director of the National Voting Rights Project of the American Civil Liberties Union, addressed a luncheon at the Boston offices of the Bingham McCutchen law firm on October 16th. He noted that before 2008, only two states had restrictions on voter registration which required the presentation of one of a small number of government-issued IDs bearing a photograph. By August, 2012, twelve states had such a provision. In 2013, after the United States Supreme Court struck down Section 5 of the Voting Rights Act of 1965, thirteen more states adopted new restrictive laws, many of similar import.

It seems statistically irrefutable that the effect of these various laws work against young people, and racial minorities, getting to the voting booth. These laws come in several flavors, and while many laws require photo IDs which may be difficult to obtain (elderly without drivers licenses in Texas may need to travel 250 miles to reach the Texas equivalent of the Department of Motor Vehicles in order to obtain a license), other provisions include: shrinking the period of time prior to an election that early voting can occur; preventing early voting on the day before election day (cutting into the practice of poorer churches that on Sunday they organize voters and on the following Monday, the day before election day, they drive them to the polls); requiring registration of individuals who assist people in obtaining voter status, and requiring their filing of monthly state reports (struck down by the courts); elimination of pre-registration qualification for younger teens; elimination of a civics course in high school.

Prior to 2008, most voter litigation involved improper districting (gerrymandering). Since 2008, almost all the litigation involves voter ID and related new state regulations. The Civil Liberties Union and other groups are sometimes, but not always, successful in barring the operation of these voter limitations either in Federal Court or in State Courts.

Finally, there was discussion of laws limiting rights of felons, once released from incarceration, to vote. Felony convictions fall disproportionally on minority groups. Four states permanently bar felons from voting, and other states have varying disqualification provisions. The United States has the highest incarceration rate of any Western democracy. If all the people presently in prison for felonies were to be organized into a state, that state would have six votes in our Electoral College.

Conclusion: There is going to be voter access litigation for a long time to come.

I’ve Been Thinking….

What about those radio ads for hospitals that say they focus on the human being and his comfort, that you were a human being before being a patient? Next they say the most important thing is to get the best possible medical care. A total logical disconnect, just words that sound good even if they are inconsistent.

When did they start putting advertising into cable TV movies? I will never forgive Volvo as a prime offender.

Why don’t our gubernatorial candidates tell us where they stand on the gambling referendum, or on passing a Massachusetts law banning noncompetition agreements like California? Why are they fighting over who loves children more?

When did television become standard in restaurants? Doesn’t the TV noise interfere with all the diners who are texting?

Why is it necessary in restaurants to purposely design the space to maximize noise, which is defined as energy and viewed as hip, young and modern? Where does an older American go these days for a peaceful meal? Maybe the idea is, “no problem, those guys can’t hear anything anyway.”

Now that the Turks are fighting the Kurds who are the only credible ground force opposing ISIL, and since our strategy is to drop bombs and leave the clearly required ground offensive to others, does this mean the President will have to commit US troops and, if so, will he do it before the election?

There are so many different factions fighting in the Mid-East that I have given up keeping track; my map of the area, in my den, has not been updated with small yellow stickies in weeks. Seems you need to know who is fighting whom on a tribe-by-tribe, or block-by-block basis. No wonder our government seems confused, we cannot even be saved by our Secretary of State’s sonorous voice.

Why do we have baseball playoffs, rewarding teams that get temporarily hot or have traded well on August 31, rather than having a single World Series between the two teams that put in the best hard work during the entire full six-month season?

Oh yeah; it’s the money….

Who else would like to seal our borders against Ebola, disbelieving this is not going to seriously mess with us? (No surprise: my test audience of two people who were exposed to this idea promised me that I was hopelessly naive to think this was possible.)  I can see a three part made-for-TV series: in episode one an outbreak in Africa spreads through the continent (sound familiar?); in episode two, the disease pops up in random places while governments, in an effort to maintain calm and in defiance of warnings from some, continue to reassure and counsel life as usual (sound familiar?); in episode three, the surviving 42 people in the world try to find each other to build a society (or at least mate and drink the remaining fine wine before it sours).

Did you ever notice in the apocalypse movies that the survivors represent a cross section of the world, different races, backgrounds, skill sets, age, degree of lawlessness? What if a genetic or random quirk defined the survivors and they all were of a single sort? All over 7 feet tall. All from Albania. Or all from Newark? Or all Kansas City Royals fans….

Trending M&A

What is happening in the M & A markets during 2014? The short answer is: so far, 2014 is the most active year for United States M & A since 2008 (we all know what happened after 2008).

The current and future state of the market was discussed at the Practicing Law Institute panel held in New York on October 2, 2014, led by senior investment bankers from Lazard and Goldman Sachs.

United States target M & A volume was up 79% from 2013, through mid-August, driven in part by increased frequency of “mega deals”. Nearly 30% of the announced M & A volume arose from transactions in excess of $10 Billion.

There also was a significant upswing in strategic purchases. Part of this trend was driven by private equity firms partially divesting to corporate buyers. Meanwhile, leveraged buyouts by management remained depressed.

Were buyers paying cash? Almost 40% of M & A involved payment in some stock, and 15% of acquisitions were all-stock deals. Of course, when you are talking mega-transactions, it is difficult to come up with all that cash and, hence, the resurgence of paper.

Possible drivers which helped increased M & A: growth in hostile takeover attempts; pressure by shareholder activists seeking, in many instances, to break up larger companies; low interest rates; lots of dry powder on corporate balance sheets; positive performance of the equity markets which made payment in stock more palatable than in the recent past.

Where will M & A trend for the balance of the year and into 2015? While the prognosis expressed was generally positive, with sustained M&A activity assisted by projected modest but continued increase in the S&P, several warnings were noted: the world has become a more dangerous place which, in turn, increases business risk; some current deals may prove over-leveraged, and their weaknesses may trickle back into the marketplace and depress valuations, discouraging sellers; conversely, continued increased price multiples perhaps will dampen the enthusiasm of private equity buyers.

Trends in Med Device Compensation

 

At the September 16th meeting at MassMEDIC (the association of medical device manufacturers), the folks from Radford, leading compensation consultants, made a comprehensive presentation of trends in med device compensation.

Radford reports that salary budgets have been almost flat for the last two years, but a greater uptick is expected in 2015. Most interesting is the difference in the ways in which public and private med device companies structure their compensation.

Generally, privately owned firms compare themselves to a peer group within their industry with similar levels of invested capital, revenue, development stage and employee count; base salaries, which for a while were low-balled, now are viewed as necessarily competitive, with annual bonuses becoming more prevalent. Most importantly, equity is aggressively distributed, typically in the form of stock options, with awards being measured against ownership percentage in the enterprise.

Public companies identify with a small peer group of public companies with particular reference to market cap, R&D spending and product stage. More of the cash goes into an annual bonus and not into base. Equity is more parsimoniously distributed, with a strong movement toward restricted stock units. Units are issued based on their value in absolute dollars in relationship to overall compensation. Additionally although not surprisingly, as companies grow from private to small public to large public, the bonus metric becomes much more focused on profits.

The most predictable aspect has to do with the progression of executive compensation through the company tiers. Each of base salary, total cash compensation (including bonuses) and long term incentives increases as the company moves from private to small public, and from small public to large public status. This is true not only at the CEO level but also at the CFO level.

Finally, what Radford characterized as a “hot IPO marketplace” has heightened the interest of all employees, in companies of all stages, in equity compensation. This is just a matter of common sense, reflecting the general recovery of the securities markets and the robust performance of life science equities in particular, and consequently the greater potential appreciation values hoped for from the equity portion of comp.

No doubt public device companies are informed, with respect to their information concerning their peer groups, by SEC disclosure of compensation, which has been heightened over the last several years. Since practices in private companies are materially disparate in numerous areas, reference to public company disclosure for this cohort is not going to prove fruitful. For this private cohort, experience in actual hiring will be informative to management, as people are marked to market in an increasingly competitive hiring environment.

Can med device employers hold on to their employees, in this more mobile environment, by vigorous use of noncomp agreements? See my post of September 17th for the answer to that question.

Finally, hats off to the folks at Radford, upon whom I have wholly relied for the data in this post (interpretive commentary should be attributed to and blamed upon me alone).

Boston Olympics? More than Meets the Eye

Suffolk Construction CEO John Fish leads the committee exploring bringing the 2024 Summer Olympic Games to Boston. His reasons, however, are likely not what you expected.

Delivering remarks at the National Association of Corporate Directors/New England September 18th breakfast meeting, Fish emphasized that attempting to attract the Olympics was not just about the Olympics. Although I am sure that he would consider Olympics Games in Greater Boston to be a lot of fun (he never actually said as much), his foci were directed elsewhere.

First, he noted that the development of a robust infrastructure to support the movement, housing, feeding and care of an expanding workforce, regardless of whether the Olympics come to Boston, was a necessary component of robust economic growth. The Olympics could feed into the build-out of that infrastructure, by creating sustainable space which could be utilized as part of that future infrastructure. He sees the Olympics as getting a head start on future development.

Second, in developing Boston’s Olympics proposal, the committee convened many experts in data analysis. What events would be held in which venues and at what time? Where should the housing and support functions be located? What will be the impact on participants and the general population in different locations for pedestrians, drivers, workers, people seeking food or other services? The committee has developed a computerized model to analyze data for all locations relevant to the Olympic Games, and to do so hour by hour. For example [which I am suggesting, this was not made express at the meeting], let us assume there is a hockey game at the Harvard Hockey Arena on a Thursday. Should that be held at 10:00 in the morning, 2:00 in the afternoon or 8:00 at night? What will be most crowded, least crowded, most supported, least intrusive on the different constituencies and how do you address those issues by planning?

Fish cannot say whether Boston will receive the United States recommendation, and thereafter the International Olympic Committee approval, but he hopes that the information-based tools they have developed can be utilized in the future for planning infrastructure build-out.

A week or two ago, the Globe printed a map of Greater Boston with an indication of how the Olympics might fit into existing facilities, and into newly built facilities which could be repurposed after the Games concluded. I recall, at the time, not understanding the logic of how locations were being assigned; having heard Fish speak with respect to the data-driven methodology behind the plan, the logic of the proposal now becomes clear.

Business in China: How to?

Economic growth in China may have slowed, but it has slowed to an annual rate which for the foreseeable future, claims GE Chairman Jeff Immelt, will be between 7% and 8%. I note that this is more robust than predicted growth in other developed economies. Consequently, China should be on one’s mind.

Immelt and the rest of his panel (Suffolk Construction CEO John Fish and Simmons Business School Dean Cathy Minehan) discussed China at the September 18th meeting of the National Association of Corporate Directors/New England, before approximately 200 corporate directors and business leaders. Herewith some of the major take-aways with respect to China:

The best people in China are in government, not industry. They are well-educated with world views. While certain reforms are necessary, there remain some impediments to those reforms. The central government has been centralizing power of late (not necessarily a favorable development), in light of corruption and suspicions with respect to party loyalty. One must be careful in doing business with China.

It is necessary to appreciate the vantage point of the Chinese government, according to Immelt. Their constant primary concern is: how do I house and feed 1.3 billion people? A business plan that is part of that solution will succeed.

So China will be a growth market but there will be risks. You can’t approach China just as a market; they want business to build things within China. This recognizes that one manufacturing job does not create just one manufacturing job; people working in the supply chain may bear an 8-to-1 ratio to the actual number of workers in a given factory.

GE does not “bet the ranch in China,” Immelt stated. He follows events in the country closely, and every single decision with respect to business in China, on the part of GE, is made by him personally.

A bit sobering, I think.